Mi-acid Regular Strength
NDC Package 64725-0004-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mi-acid Regular Strength is • shake well before use• adults and children 12 years and older: take 2 to 4 teaspoonfuls between meals, at bedtime, or as directed by a doctor• do not take more than 24 teaspoonfuls in 24 hours or use the maximum dosage for more than 2 weeks• children under 12 years: ask a doctor. Marketed by Tya Pharmaceuticals, this product is identified by NDC 64725-0004 and is authorized under FDA application part331.

Identification & Billing

NDC Package Code
64725-0004-1
Package Description
12 mL in 1 BOTTLE
Product Code
64725-0004
11-Digit Billing Format
64725000401
RxNorm Crosswalk
  • RxCUI: 210036 - Mi-Acid 200 MG / 200 MG / 20 MG in 5 mL Oral Suspension
  • RxCUI: 210036 - aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension [Mi-Acid]
  • RxCUI: 210036 - Mi-Acid (aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG) per 5 ML Oral Suspension
  • RxCUI: 210036 - Mi-Acid (aluminum hydroxide 40 MG / magnesium hydroxide 40 MG / simethicone 4 MG) per ML Oral Suspension
  • RxCUI: 210036 - Mi-Acid (aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG) per 10 ML Oral Suspension

Clinical Specifications

Proprietary Name
Mi-acid Regular Strength
Dosage Form
-
Usage Information
• shake well before use• adults and children 12 years and older: take 2 to 4 teaspoonfuls between meals, at bedtime, or as directed by a doctor• do not take more than 24 teaspoonfuls in 24 hours or use the maximum dosage for more than 2 weeks• children under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Tya Pharmaceuticals
FDA Application #
part331
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-01-2011
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64725-0004-1 identifies a specific commercial package of 12 ml in 1 bottle of Mi-acid Regular Strength, labeled by Tya Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tya Pharmaceuticals on February 01, 2011. The current certification is valid through December 31, 2017.

How is this Tya Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64725000401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
64725-0004-1
11-Digit CMS (5-4-2)
64725-0004-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.